Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT1 | Q99873 | 1/20 | 0.59 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | POLB | P06746 | 2/20 | 0.52 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | EPHX2 | P34913 | 7/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.46 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.46 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.45 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.45 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.45 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.45 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.45 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.45 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.45 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11133362 | 1.00 | PRMT1 (0.59) | PRMT1ADRA1AALDH1A1POLBTAAR1 | |
| SCHEMBL11133946 | 1.00 | PRMT1 (0.59) | PRMT1ADRA1AALDH1A1POLBTAAR1 | |
| SCHEMBL11141321 | 1.00 | PRMT1 (0.59) | PRMT1ADRA1AALDH1A1POLBTAAR1 | |
| SCHEMBL515857 | 1.00 | PRMT1 (0.59) | PRMT1ADRA1AALDH1A1POLBTAAR1 | |
| SCHEMBL81977 | 1.00 | PRMT1 (0.59) | PRMT1ADRA1AALDH1A1POLBTAAR1 | |
| SCHEMBL11137045 | 1.00 | PRMT1 (0.59) | PRMT1ADRA1AALDH1A1POLBTAAR1 | |
| SCHEMBL24686717 | 1.00 | PRMT1 (0.59) | PRMT1ADRA1AALDH1A1POLBTAAR1 | |
| SCHEMBL8779381 | 1.00 | PRMT1 (0.59) | PRMT1ADRA1AALDH1A1POLBTAAR1 | |
| SCHEMBL8779440 | 1.00 | PRMT1 (0.59) | PRMT1ADRA1AALDH1A1POLBTAAR1 | |
| SCHEMBL11136996 | 1.00 | PRMT1 (0.59) | PRMT1ADRA1AALDH1A1POLBTAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11208451-B2 | Protein and protein conjugate for diabetes treatment, and applications thereof | ADDA BIOTECH INC. | 2021-12-28 | — | — | US | disclosed |
| US-10472404-B2 | Protein and protein conjugate for diabetes treatment, and applications thereof | ADDA BIOTECH INC. (CN) | 2019-11-12 | — | — | US | disclosed |
| EP-2851429-B1 | PROTEIN AND PROTEIN CONJUGATE FOR DIABETES TREATMENT, AND APPLICATIONS THEREOF | ADDA BIOTECH INC (CN) | 2019-07-24 | — | — | EP | disclosed |
| US-9745359-B2 | Protein and protein conjugate for diabetes treatment, and applications thereof | ADDA BIOTECH INC. (CN) | 2017-08-29 | — | — | US | disclosed |
| US-20170233447-A1 | PROTEIN AND PROTEIN CONJUGATE FOR DIABETES TREATMENT, AND APPLICATIONS THEREOF | ADDA BIOTECH INC. (CN) | 2017-08-17 | — | — | US | disclosed |
| US-20150183847-A1 | PROTEIN AND PROTEIN CONJUGATE FOR DIABETES TREATMENT, AND APPLICATIONS THEREOF | ADDA BIOTECH INC. (CN) | 2015-07-02 | — | — | US | disclosed |
| EP-2851429-A1 | PROTEIN AND PROTEIN CONJUGATE FOR DIABETES TREATMENT, AND APPLICATIONS THEREOF | Adda Biotech Inc. (CN) | 2015-03-25 | — | — | EP | disclosed |
| EP-0507348-B1 | Superoxide dismutase derivatives | KURARAY CO (JP) | 1997-07-09 | — | — | EP | disclosed |
| US-5360914-A | Intermediates for superoxide dismutase derivatives | KURARAY CO., LTD. (JP) | 1994-11-01 | — | — | US | disclosed |
| US-5238837-A | Antiinflammatory agents, antiulcer agents | KURARAY CO., LTD. (JP) | 1993-08-24 | — | — | US | disclosed |
| EP-0507348-A2 | Superoxide dismutase derivatives | KURARAY CO., LTD. (JP) | 1992-10-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11208451-B2 | Protein and protein conjugate for diabetes treatment, and applications thereof | GLP1R, GIPR, IAPP | PRMT1 910/4885ADRA1A 1469/4885ALDH1A1 3111/4885 |
| US-10472404-B2 | Protein and protein conjugate for diabetes treatment, and applications thereof | GLP1R, GIPR, IAPP | PRMT1 910/4885ADRA1A 1469/4885ALDH1A1 3111/4885 |
| US-20150183847-A1 | PROTEIN AND PROTEIN CONJUGATE FOR DIABETES TREATMENT, AND APPLICATIONS THEREOF | GLP1R, GIPR, IAPP | PRMT1 950/4885ADRA1A 1483/4885ALDH1A1 3100/4885 |
| US-20170233447-A1 | PROTEIN AND PROTEIN CONJUGATE FOR DIABETES TREATMENT, AND APPLICATIONS THEREOF | GLP1R, GIPR, IAPP | PRMT1 910/4885ADRA1A 1469/4885ALDH1A1 3111/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.